Malignant Bone Marrow Neoplasm — Trials

Malignant Bone Marrow Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,612 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,035
Recruiting: 592
Ph III recruiting: 61
Growth YoY: +8.1%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (801)

clinicaltrialsPublishedShowing 301–350 of 902 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02708641	A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML	completed	Phase 2	12	Michael BoyiadzisOTHER	1	Aug 10, 2021	clinicaltrials
NCT01221857	Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies	completed	Phase 1 / Phase 2	12	Gamida Cell ltdINDUSTRY	1	Aug 3, 2021	clinicaltrials